89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 88 filers reported holding 89BIO INC in Q3 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $486 | +221.9% | 60,648 | +366.5% | 0.06% | +243.8% |
| Q1 2024 | $151 | -65.0% | 13,001 | -66.3% | 0.02% | -65.2% |
| Q4 2023 | $431 | +48.1% | 38,545 | +104.9% | 0.05% | +58.6% |
| Q3 2023 | $291 | +49.2% | 18,815 | +82.7% | 0.03% | +16.0% |
| Q2 2023 | $195 | -31.6% | 10,300 | -53.9% | 0.02% | -10.7% |
| Q4 2022 | $285 | -99.5% | 22,362 | +109.4% | 0.03% | +366.7% |
| Q3 2022 | $62,000 | – | 10,679 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 400,000 | $1,288,000 | 6.98% |
| TCG Crossover Management, LLC | 1,133,196 | $3,649,000 | 1.55% |
| GREAT POINT PARTNERS LLC | 1,400,000 | $4,508,000 | 1.08% |
| DAFNA Capital Management LLC | 766,774 | $2,469,000 | 0.67% |
| RA Capital Management | 7,782,669 | $25,060,000 | 0.67% |
| BVF INC/IL | 3,898,000 | $12,552,000 | 0.61% |
| Boxer Capital, LLC | 1,400,000 | $4,508,000 | 0.29% |
| Orbimed Advisors | 3,658,869 | $11,782,000 | 0.21% |
| Newtyn Management, LLC | 310,000 | $998,000 | 0.19% |
| Orchard Capital Management, LLC | 168,493 | $592,000 | 0.18% |